Asset

Cetirizine hydrochloride

Harrow Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 208694NDAHARROW EYE LLC

Marketed products (1)

  • ZERVIATE